<DOC>
	<DOCNO>NCT00406094</DOCNO>
	<brief_summary>The purpose trial determine patient NARES treat montelukast ( Singulair ) improve nasal symptom score reduce nasal eosinophil .</brief_summary>
	<brief_title>Singulair Use Non-Allergic Rhinitis Eosinophil Syndrome ( NARES )</brief_title>
	<detailed_description>Patients receive either montelukast placebo treatment NARES . 4 visit conduct 12 week . A history physical perform begin trial end . Skin test do Visit 1 . Nasal smear lavage perform every visit . Patients compensate time travel .</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Aged 18 65 year Diagnosed NARES Smokers , expose passive smoke Diagnosis seasonal allergic rhinitis ( SAR ) , perennial allergic rhinitis ( PAR ) , vasomotor rhinitis ( VMR )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>NARES</keyword>
	<keyword>eosinophil</keyword>
	<keyword>nasal symptom</keyword>
</DOC>